Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Josiane Lederman

Dermatology Staten Island, NY Medical Doctor

NPI 1619981511 CMS profile 163609

116 Lamberts Ln, Staten Island, NY 10314

Open in the dashboard

General payments

$20,185

423 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Josiane Lederman of Staten Island, NY is reported in the CMS Open Payments database as having received $20,185 across 423 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,022 48
2024 General $1,632 54
2023 General $4,765 80
2022 General $2,706 61
2021 General $3,198 70
2020 General $1,874 45
2019 General $4,987 65

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Josiane Lederman
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Josiane Lederman were reported at $1,022. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Josiane Lederman Dermatology median Middle half National median
2019 $4,987 $454 $129–$1,240 $163
2020 $1,874 $235 $81–$756 $114
2021 $3,198 $377 $108–$1,108 $132
2022 $2,706 $514 $143–$1,391 $149
2023 $4,765 $607 $159–$1,674 $160
2024 $1,632 $751 $204–$1,903 $164
2025 $1,022 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Merz North America, Inc. $13,350 96 payments
  2. Janssen Biotech, Inc. $3,171 158 payments
  3. Galderma Laboratories, L.P. $452 24 payments
  4. Medimetriks Pharmaceuticals, Inc. $350 1 payment
  5. Lilly USA, LLC $302 16 payments
  6. Genzyme Corporation $301 14 payments
  7. Novartis Pharmaceuticals Corporation $261 13 payments
  8. LEO Pharma Inc. $221 13 payments
  9. Boehringer Ingelheim Pharmaceuticals, Inc. $197 8 payments
  10. AbbVie, Inc. $186 10 payments
  11. Other $1,393 70 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $19,319 416 payments
  2. Education $516 6 payments
  3. Consulting Fee $350 1 payment
Products named General payments · program years 2019–2025
  1. Xeomin Dermatology $5,590 44 payments
  2. ASCLERA $3,089 24 payments
  3. TREMFYA $2,855 123 payments
  4. Xeomin musculoskeletal $2,032 15 payments
  5. SIMPONI ARIA $558 45 payments
  6. STELARA $558 45 payments
  7. SIMPONI $558 45 payments
  8. REMICADE $428 36 payments
  9. Neo-Synalar $350 1 payment
  10. Clindacin ETZ $350 1 payment
  11. Other $3,815 182 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

277

Median for Dermatology: 534

Drug cost

$5,446

Median for Dermatology: $67,151

Branded share of claims

7.6%

Median for Dermatology: 8.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ketoconazole Generic 70 $1,216
Clindamycin Phosphate Generic 26 $974
Metronidazole Generic 17 $886
Clobetasol Propionate Generic 18 $833
Triamcinolone Acetonide Generic 69 $589
Cephalexin Generic 23 $286
Betamethasone Diprop Augmented Betamethasone/Propylene Glyc Brand 21 $280
Doxycycline Hyclate Generic 11 $245
Mupirocin Generic 22 $138

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,550 Part D prescribers listed as Dermatology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 60 billing codes

Paid by Medicare

$326,883

Of which drugs: $15,863

Medicare patients

733

Average age 73

Services billed

5,006

406 women, 327 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 51%
Diabetes 42%
Ischemic heart disease 32%
Chronic kidney disease 20%
Cancer 15%
Depression 14%
Atrial fibrillation 13%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) J7308 Office 39 51 $15,801
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 29 78 $59

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 18 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
TREMFYA
  • Janssen Biotech, Inc. $583
$583 — —
Xeomin
  • MERZ NORTH AMERICA, INC. $376
$376 — —
CYLTEZO
  • Boehringer Ingelheim Pharmaceuticals, Inc. $158
$158 — —
SKYRIZI
  • AbbVie, Inc. $67
$67 — —
VTAMA
  • Dermavant Sciences, Inc. $59
$59 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 18 in the dashboard with a free account

Records

423 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record